Group Health Research Institute - Seattle

Seattle, Washington 98101-1466

0 studies enrolling now · 10 studies all time

What they study most

Bacillus Anthracis (Anthrax), Diphtheria, Influenza, Pertussis, Rotavirus Infection, Smallpox, Tetanus

Studies at this site

• Lyophilized IMVAMUNE® (1x10^8 TCID50) Versus Liquid IMVAMUNE® (1x10^8 TCID50) Administered Subcutaneously and a Lower Dose Liquid IMVAMUNE® (2x10^7 TCID50) Administered Intradermally — Completed
• Post-Partum Immunization With Live Attenuated Influenza Vaccine (LAIV) or Trivalent Influenza Vaccine (TIV) in Post-Partum Breast Feeding Women — Completed
• Sanofi H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly Populations — Completed
• 2010-2011 Trivalent Influenza Vaccine (TIV) in Pregnant Women — Completed
• Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules — Completed
• Pertussis Vaccine in Healthy Pregnant Women — Completed
• Assessment of the Immunogenicity and Safety of a Dose-Sparing BioThrax® AVA Schedule — Completed
• Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Adult and Elderly Populations — Completed
• Booster Trial to 07-0019 With A/Anhui/05 With and Without MF59 — Completed
• H5N1 Mix and Match With AS03 — Completed